Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphorylase kinase (PhK) is a large, multi-subunit serine/threonine-specific protein kinase that plays a central role in glycogen metabolism. Its primary function is to activate glycogen phosphorylase by phosphorylation, thereby promoting the breakdown of glycogen into glucose-1-phosphate. The holoenzyme has a complex quaternary structure composed of four types of subunits: α (alpha), β (beta), γ (gamma; catalytic subunit), and δ (delta; regulatory/calmodulin subunit). PhK activity is tightly regulated through multiple mechanisms, including allosteric regulation by calcium ions and reversible phosphorylation by protein kinase A (PKA).
Not applicable, direct inhibitors currently unknown
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphorylase Kinase (PhK).